Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Transcripts

Read transcripts of webcasts and audiocasts

Transcripts

Read transcripts of webcasts and audiocasts

All regions
Denmark
Sweden
Finland
Norway
Latest
Trending
Followed

Valmet, Audiocast, Q2'26

By Inderes7/24/2026, 7:00 AM
Valmet

Disclaimer: This is a machine-generated transcript and may contain inaccuracies.

Pekka Rouhiainen
00:00 - 01:29

Good morning, everyone, and welcome to Valmet's second quarter 2026 results webcast. I am Pekka Rouhiainen from Investor Relations. And with me today are Valmet President and CEO, Thomas Hinnerskov, and our CFO, Katri Hokkanen. Before we begin, I would like to briefly mention the separate stock exchange release we published this morning. Valmet's Board of Directors has initiated a strategic review regarding a potential separation of the company's two business segments, Biomaterial Solutions and Services and Process Performance Solutions, into two standalone publicly listed companies. We are pleased to be able to share this important strategic step with you today. Next, Thomas will start by discussing the continued strategic development of Valmet, including the recently completed Severn acquisition and the strengthening of our Process Performance Solutions business. He will explain how these developments have led to the strategic review we announced today. He will then move on to review the key highlights and operational performance for the second quarter, and Katri will cover the financial development in more detail, after which Thomas will return to discuss our guidance and market outlook. As usual, you may submit written questions through the webcast platform at any time, and we will then also open up the lines for Q&A. But with that, Thomas, the floor is yours.

Thomas Hinnerskov
01:30 - 20:22

Thank you. Pekka. As mentioned, I will start by discussing the recent Severn acquisition and how we are continuously and strategically developing Valmet's portfolio. Before turning to those topics, however, let me just make one comment on our Q2 performance. For me, the second quarter, which was relatively strong in terms of net sales and comparable EBITA and also order intake, showed that Valmet continues to move in the right direction. Our strategic actions are delivering results. Our competitiveness remains strong, and we continue to strengthen the company for the long term. While I will come back to our Q2 performance in more detail shortly, the strength of those results provides an important context for the strategic step that we announced earlier this morning. Now with that, let me begin with Severn. As you well know, on July 1st, we successfully completed the acquisition of Severn and welcomed approximately 950 new colleagues to Valmet. It was really great to be in Houston on the day, meeting colleagues there, having the opportunity to talk to many of them in person, and also walking the shop floor there. Severn is a well-established industrial company specializing in severe service flow control solutions. Severn generated approximately $205 million of net sales in 2025, with a comparable EBITA margin of around 16%. The business has an excellent strategic fit and also cultural fit with Valmet and brings valuable technology, expertise, and customer relationships to Valmet. So we are extremely happy to be able to start working with our new colleagues and customers. It's important to highlight how the Severn acquisition strengthens our Process Performance Solutions segment and accelerates Valmet's growth beyond the traditional biomaterial markets. Severn expands our addressable market and increases our installed base. It creates new opportunities in lifecycle services and aftermarket business with the acquired business included. Our Process Performance Solutions segment annual net sales will now be approximately 1.7 billion on an annual basis. At this scale, we can respond faster to customers wherever they operate and invest with more conviction in the technology and service capabilities they need. In fact, during the first week since the closing, we have already seen significant interest from new kinds of customers towards the Process Performance Solutions portfolio, and not just towards flow control, but also towards our broader portfolio, including automation solutions. That leads us to today. This leads to today's strategic announcement that Pekka mentioned earlier. As highlighted by the Severn acquisition, Process Performance Solutions has indeed developed into a large, highly profitable business. Together with the strong Biomaterial Solutions and Services, this has led us to ask ourselves the important strategic question: could these two businesses create even more value for shareholders as independent companies than they can together? To really look into this question, we have decided to initiate a strategic review to evaluate a potential separation of Biomaterial Solutions and Services and Process Performance Solutions into two standalone publicly listed companies. Let me emphasize one point immediately. Today's announcement is about initiating a review. No decision has been made to implement a separation. There is no certainty that the review will lead to a transaction or a structural change. The purpose of the review is solely to assess whether separation could create additional long-term shareholder value compared with the current combined structure. We expect to provide an update no later than in connection with the publication of our full-year 2026 results. Now, let me explain further why we believe this is the right time to start this review. The automation business we acquired in 2015 was highly complementary to Valmet's core biomaterial business at the time. Back then, around 80% of the business came from Valmet's traditional customer industries, making the industrial logic and customer synergies very strong. Over the past decade, through successful execution, organic growth, and strategic acquisitions, we've transformed that business substantially. Today, Process Performance Solutions is no longer primarily an automation business servicing pulp and paper customers, but instead includes equally strong automation and flow control businesses servicing a versatile group of customers. In fact, currently, up to 70% of the segment's order intake comes from industries outside pulp and paper. Many of them link to long-term trends such as energy transition, industrial efficiency, and digitalization. This is a significant shift, and as discussed, the acquisition of Severn further strengthened these characteristics. At the same time, the Process Performance Solutions segment has developed into a major earnings engine in its own right. Today, this segment generates more than 300 million of comparable EBITA on an annualized basis and contributes nearly half of Valmet's total comparable EBITA. In other words, what started as a highly complementary business supporting Valmet's core biomaterial offering has evolved into a scaled, high-margin growth platform with its own attractive end markets, growth drivers, and value creation opportunities. As a result, Valmet today consists of two large, profitable businesses with strong market positions and the scale to succeed independently. On the left, Process Performance Solutions. As discussed earlier, this business has grown significantly in scale, profitability, and strategic importance. It serves a diversified base of industries with mission-critical automation and flow control solutions, and close to 70% of order intake already comes from outside the pulp and paper industry. Then, on the right, Biomaterial Solutions and Services. This traditional part of the business has also created substantial value over time since Valmet was formed in 2014. Net sales have grown from €2.5 billion to nearly €4 billion, and the share of services has increased to 55%. This marks a clear shift towards a more resilient, service-led business, with a high level of recurring revenue. At the same time, our margins have improved from around 2% to close to 10%. Importantly, we're not standing still. In today's complex market environment. In fact, periods like this are often the best time to drive meaningful change through the operating model renewal. Through the global supply transformation, we are strengthening customer productivity, increasing our focus on aftermarket opportunities, improving procurement, and optimizing our manufacturing footprint. These actions are already visible in the steps we've taken, including the facility closures announced earlier this year in both Europe and China. They position us to emerge stronger, gain market share in services, and continue improving profitability as market conditions recover. Today, Biomaterial Solutions and Services is a global technology leader and lifecycle service leader, servicing customers across pulp, board, paper, tissue, as well as energy. We are at the core of our customers' operations; from the initial technology investments to decades of lifecycle services, we help keep their production running safely, efficiently, and competitively every day. What gives us confidence in the future is that we are building on an already strong foundation. We have strengthened the business significantly over the last decade, and we are taking further actions today to increase customer proximity, growth, service, and improve profitability. We believe the next chapter is still ahead of us. In conclusion, this review reflects the fact that both businesses have developed into strong and successful operations with distinct business models, growth opportunities, and capital allocation profiles. This naturally leads to the question of where additional value creation might come from. At this stage, we see three potential areas where a separation could create additional shareholder value. First, more focused strategies. Each business operates in different competitive environments, serves different customer needs, and pursues somewhat different growth opportunities. Greater independence may allow each business to make its own decisions entirely based on its own priorities and market dynamics. Second, more tailored capital allocation. The businesses have different investment requirements and different opportunities for both organic and inorganic growth. Also, as we highlighted in our Capital Markets Day last year, the M&A potential is clearly higher in Process Performance Solutions with a focus on opportunities outside of the pulp and paper industry. A separation may allow each company to allocate capital in a more targeted way, aligned with its own economics and strategic priorities. Third, clear accountability and investment propositions. Separate management teams, boards, and capital allocation frameworks could improve transparency and allow investors to assess each company against the performance drivers most relevant to that business. At the same time, we do recognize that a potential separation would also involve costs and other impacts. That is exactly why we are conducting a comprehensive review rather than making a decision today. We'll only proceed if the review demonstrates that the long-term benefits clearly outweigh the cost, complexity, and execution risk associated with such a separation. Finally, one more important note: around today's announcement, nothing changes for our customers, our employees, or our day-to-day operations. Business continues as normal. The review does not change our strategy. Customer commitments, deliveries, projects, and services remain unchanged, and our teams remain fully focused on executing and servicing our customers. In a scenario where a separation were eventually pursued, one of the key objectives would be to preserve that customer value. This will remain an important consideration throughout the review process. The strategic, financial, and operational implications of a potential separation will now be assessed carefully. The board will only move forward if there is clear evidence of enhanced shareholder value creation. With that background, we can now turn to our second quarter performance. We will get back to the strategic review in due time. Now, the first part of the presentation focused on the strategic development of Valmet. The quarter in itself clearly demonstrates the benefits of the strategic actions we have already taken over the past year. First of all, the decisive action we took last year to strengthen Valmet's competitiveness has continued to deliver. During the quarter, net sales increased 6% organically and comparable EBITA increased to 152 million. Comparable EBITA margin remained stable at 11.5%, supported by higher net sales and cost savings. On a year-to-date basis, comparable EBITA is now slightly ahead of last year, demonstrating the resilience of our full-year trajectory despite the softer start to 2026. Orders received totaled close to 1.4 billion, while orders decreased 9% from the comparison period, which was mainly driven by our capital project order intake in the Biomaterial Solutions and Services segment. Orders increased sequentially from Q1 and were at a solid level. While uncertainty remains in the market. We saw some early signs of stabilization in the Biomaterial Solutions and Services segment during the quarter. Capital project activity improved sequentially from an unusually low level seen in Q1. The service market remains soft but did show signs of stabilization. While this is a positive development, it is important to note that the timing of large customer investment decisions continues to have a significant impact on quarterly activity, and we would not yet characterize this as a definitive market turning point. Process Performance Solutions continues to perform well and continues to deliver resilient growth and strong profitability. As I just briefly explained, the successful completion of the Severn acquisition marked another important step forward in strengthening our Process Performance Solutions business and long-term earnings profile based on our first-half performance and current visibility. We reiterate our guidance for 2026. Looking then at the orders received, orders amounted to 1.4 billion, decreasing 9% organically compared to a strong comparison period last year. Despite the year-on-year decline, 1.4 billion euros represents a solid level of order intake in the current market environment. While orders included one single triple-digit order, overall order intake was quite broad-based. Orders include several mid-sized capital orders across geographies and across customer industries, demonstrating the breadth of our offering and customer base. With that, let's take a closer look at the segment performance. Turning to Process Performance Solutions, we delivered another solid quarter. Orders increased organically by 1% with similar development in both Automation Solutions and Flow Control. This reflects the resilience of the business and the benefits of our broad industry exposure. With Flow Control, demand remained healthy across several customer segments, and Automation Solutions continued to see especially good activity in the marine segment with notable new wins. Net sales remained at the previous year's level. Flow control continued to grow, while Automation Solutions was lower than the comparison period. Comparable EBITA increased to 69 million and the margin improved to 18.7%. Profitability remained at a high level and was supported by strong operational execution. While we're very pleased with the current performance, our focus is not on maximizing short-term margins. We continue to invest selectively in growth opportunities within Process Performance Solutions. The recent acquisition of Severn is a good example of this approach. The transaction is primarily a growth and strategic positioning opportunity and not a cost synergy case, focusing on expanding our market reach, installed base, and long-term growth opportunities while maintaining attractive profitability in the business. Turning then to Biomaterial Solutions and Services. Orders decreased 13% compared with a strong comparison period last year, but there were some positive sequential signs as capital project large purchase orders increased to 501 million from the first quarter, supporting our view that Q1 represented an unusually low level of capital project activity. However, while Q2 was a clear improvement, as I noted earlier, the timing of customer investment decisions continues to have a significant impact on individual quarters going forward. As Biomaterial Solutions and Services orders declined 8%, the overall market remains soft, but consumables and performance parts held up relatively well in our largest markets, North America and EMEA. Mill improvements and field service decreased from the comparison period, which was strong in those categories last year. Overall, I would say that we do see some encouraging signs in customer activity also in services. One element was the stabilization of consumable orders after several weaker quarters. There are indications that some customers are now gradually shifting focus from cost containment back towards operational performance and maintenance needs. However, it is still too early to characterize this as a broader market recovery. Net sales increased 8% organically, supported by a higher share of large projects and smaller mill improvement projects. Comparable EBITA improved to 98 million, and the margin increased to 10.4%, supported by the higher net sales. We continue to see benefits from the actions taken during the past year. The operating renewal, ongoing footprint optimization, and broader cost discipline measures are improving competitiveness and supporting profitability even as market conditions remain mixed. With that, let me hand over to Katri to take a closer look at the financial developments.

Katri Hokkanen
20:26 - 29:11

Thank you, Thomas, and good morning, everyone, also on my behalf. Happy to be here today. I will start with the group level development of net sales and profitability. Net sales increased 6% year-on-year to 1.3 billion. Currencies or M&A did not have a material impact on the figures, and organic growth was also 6%. The increase was driven by Biomaterial Solutions and Services, where net sales grew due to higher activity in large projects, including good development in the landmark Arauco project. Process Performance Solutions net sales remained at the previous year's level. Comparable EBITA increased by 9 million to 152 million from 143 million in the comparison period. The comparable EBIT margin remained at 11.5%. Higher net sales, together with continued cost savings from the operating model renewal, supported the earnings development during the quarter. As we see in the graphs, Q2 followed a rather typical seasonal pattern, and sequentially, both net sales and comparable EBITA increased from the first quarter. Overall, the quarter demonstrates that the actions taken over the past year continue to support the profitability, even in a market environment where customer decision-making remains cautious. Let's then take a look at how our cost base has developed in recent years. The benefits from the operating model renewal continue to be clearly visible in our cost base. On a last 12 months basis, comparable SG&A expenses have decreased to 905 million compared with the 2024 baseline year. SG&A expenses are now 79 million lower as a share of net sales. SG&A has improved from 18.4% to 17%. Importantly, these results reflect more than just cost reductions. The operating model renewal was designed to simplify the organization, improve accountability, and bring us closer to customers through a stronger lifecycle focus. Focus. The lower cost base is therefore a result of structural improvements in how we operate the business, rather than just short-term cost cutting. Order backlog amounted to 4.3 billion at the end of the second quarter. Compared with the year-end 2025. The backlog was 47 million lower, but remained at a healthy level. Approximately 2.2 billion of the current backlog is expected to be recognized as net sales during 2026. Based on our current delivery schedules, the backlog continues to provide good visibility for deliveries and supports our execution plans for the remainder of the year. As always, our focus remains on disciplined project execution, profitability, and cash generation. With that, let's now turn to cash flow development. Cash flow from operating activities was 65 million euro in the second quarter, compared with 79 million euro in the comparison period. The decrease was mainly related to higher net working capital. Reported net working capital included a 123 million euro dividend liability that has no cash flow impact. Excluding this liability, net working capital was 154 million higher than at the end of 2025. The development was mainly driven by project timing and phasing effects, which are typical in our business. Comparable cash conversion on a 12-month basis was 62%, which is below our historical average. It is important to remember that quarterly fluctuations in working capital and cash flow are normal at Valmet due to the project-driven nature of the business. We continue to expect cash conversion to improve during the year, supported by normal project phasing and disciplined working capital management. While quarterly fluctuations can remain significant. The balance sheet remains strong. At the end of the quarter, net debt was 965 million euros and gearing stood at 39%, compared with 42% a year earlier. Net debt to EBITDA improved further to 1.42 from 1.6 in the comparison period. The average interest rate of our debt remained stable at 3.6%, and liquidity was strong with 584 million euros in cash and cash equivalents at quarter end. In addition, the over 450 million euro revolving credit facility was fully undrawn. This balance sheet strength provided the financial flexibility needed to complete the Severn acquisition immediately after the reporting period, and this will have approximately a 15 percentage point impact on the gearing, and we are comfortable with that level given the strong cash conversion ratio. Our business inherently has seasonality. Comparable ROCE improved to 13.5% from 13.1% in the comparison period and 12.7% in 2024, as shown in the graph. Capital employed decreased by around 79 million euros compared with 2024. While we remain below our long-term ROCE target. The direction of development continues to be positive. Adjusted earnings per share increased to €0.47 from €0.23 in the comparison period. The increase in both reported and adjusted earnings per share mainly reflects the restructuring expenses related to the operating model renewal that impacted the comparison period. This slide summarizes the main financial figures for the quarter, and most of these items have already been covered, but I would like to highlight two additional observations. First, items affecting comparability amounted to -1 million during the quarter, compared with -62 million in the comparison period, and last year's figure was mainly related to restructuring expenses of the operating model renewal. Secondly, the effective tax rate was 34.7% in the second quarter, which is above our long-term average level. Valmet's tax rate typically fluctuates between quarters due to profit mix and timing effects, and as a result, the second-quarter level should not be considered indicative of a normal quarterly tax rate going forward. Our long-term average effective tax rate is approximately 25%, which we expect to continue going forward. In summary, the second quarter demonstrated continued benefits from our operating model renewal, supported by higher net sales and solid operational execution. With that, I will hand it back to Thomas to go through the guidance and short-term market outlook. Thanks.

Thomas Hinnerskov
29:12 - 33:45

Thanks, Katri. Let me now move to our guidance and short-term market outlook. We reiterate our guidance for 2026. As mentioned earlier, Valmet continues to estimate that net sales in 2026 will remain at the previous year's level, and that comparable EBITA will remain at the previous year's level or increase compared to 2025. Turning to our market outlook for Process Performance Solutions, we continue to expect the market will remain at low year-on-year growth. The segment has demonstrated good resilience throughout the first half of the year. At the same time, uncertainty related to the geopolitical situation and global economic outlook remains elevated and continues to reduce short-term visibility for Biomaterial Solutions and Services. We estimate that market activity will remain similar to the second quarter. We were encouraged by the improvement in capital project activity compared to the first quarter. However, the timing of large customer investment decisions continues to have a significant impact on activity levels in individual quarters. The Biomaterial Solutions and Services market is expected to remain soft in the coming quarters. While the overall market appears to be stabilizing compared to the beginning of the year. Overall, the external environment remains uncertain with low visibility as we look at the remainder of the year. It is worth noting that year-to-date, comparable EBITA is already slightly ahead of last year. In addition, Severn will provide a modest contribution following the closing of the acquisition. At the same time, comparability continues to depend heavily on service activity where market uncertainty remains overall. Our large installed base, strong lifecycle offering, disciplined execution, and the addition of Severn provide a solid foundation as we move into the second half of the year. Before I conclude, let me comment on another important announcement we made this morning. As you know, we announced earlier this year that she would be leaving Valmet. And since then, we've conducted a thorough search process with a number of strong candidates. I am very pleased that the process has resulted in the appointment of Pia Aaltonen-Forsell as Valmet's next CFO. Pia clearly brings a demonstrated broad financial experience and experience from leading complex global organizations. We believe she is an excellent fit for Valmet and for the next phase of our development. Pia is expected to join Valmet no later than the end of January 2027. We look very much forward to welcoming Pia to Valmet and to introducing her to many of you next year. Until Pia joins, we are naturally in the process of appointing an interim CFO, and we expect to be able to announce that during August. With that, let me conclude today with three key messages. First, our performance in the second quarter demonstrates that the actions we have taken continue to deliver. Our competitiveness remains strong, profitability has improved, and we continue to strengthen Valmet for the long term. Second, both our businesses have developed into strong, increasingly distinct platforms. Process Performance Solutions have evolved into a scaled business of approximately 1.7 billion in net sales, with growing exposure to industries critical for the energy transition. While Biomaterial Solutions and Services continue to hold a leading position in its markets and also offer significant long-term value creation potential. Thirdly, today's announcement reflects the significant progress both businesses have made, with the strategic review intended to assess how that progress and future potential can best be translated into long-term shareholder value. And we will get back to this. At the same time, our day-to-day priorities remain unchanged: servicing our customers, executing our strategy, and delivering profitable growth. So with that, I'm going to hand back to you.

Pekka Rouhiainen
33:46 - 34:24

Thank you, Thomas, for the presentations. And we now move to the Q&A session. And as usual, we will now start the Q&A session. You may ask questions either through the webcast platform in the written format or through the conference call line. So we have two questions here. First from Christiane Nygaard. Thank you, Christiane, for the question. So I will read it here. At the Q1 call, you signaled that the expected Process Performance Solutions margins would decline in order to invest back into growth. However, the Q1 margin increased. Do you still expect lower margins for the rest of the year?

Unknown 1
34:25 - 34:26

Yes, very good question, Christian.

Thomas Hinnerskov
34:26 - 35:08

Overall, we are very happy with the performance. They continue to deliver strong operational performance during the first half. Profitability has also been supported by elevated product margins. What really is important in that business is that we are happy with the level of profitability. We really want to make sure that we push the growth accelerator on that one. That is why we want to keep looking for potential investments into organic growth, although some of those growth investments may have been set back slightly due to some of the geopolitical tension that was created early on in the year.

Pekka Rouhiainen
35:10 - 35:20

Thank you. Thomas. Then another one. The anonymous question is whether the main reason behind splitting up the company is the persistent low multiples of the group.

Thomas Hinnerskov
35:23 - 36:34

Yeah. Good question. As we mentioned in this presentation, we have developed two very strong segments over the years. We introduced these segments last year at a capital markets day. Now it really is about how we can position these structurally to be in the best position for development. It is important to note that they are now servicing different customer segments to a very large extent. Only 30% of the customer segments are overlapping, right? It is also clear that both of the two different platforms have different growth agendas. One is much more. Which is the business prone for. That is why we are looking into both M&A and organic growth. Severn is a good example of that. So that means that the capital allocation for these two segments is going to be different going forward. Then as a third point, there could also be value in this. Would a separation make it a simpler equity story with dedicated KPIs for these two different segments in order to actually follow and evaluate if they are executing the strategy as communicated?

Pekka Rouhiainen
36:36 - 36:42

Great. Thank you, Thomas. That is all from the written format. Operator, I am handing over to you.

Operator
36:44 - 37:01

If you wish to ask a question, please dial pound key five on your telephone keypad to enter the queue. If you wish to withdraw your question, please dial pound key six on your telephone keypad. The next question comes from Antti Kansanen from SEB. Please go ahead.

Antti Kansanen
37:05 - 37:39

Hi. A couple of questions from me. I will take them one by one, and I will start with one regarding the potential separation of the two divisions. So Thomas, could you maybe talk a little bit about the synergies between the automation systems business and the flow business within the Process Performance Solutions segment in terms of shared client base and R&D? And then contrast the types of synergies the automation business and the pulp and paper equipment business have had historically, in terms of if these businesses end up under a separate company going forward.

Thomas Hinnerskov
37:40 - 39:16

Yes, great. Great. Thanks to you. Great to have you on the call, Antti. Let me just write down. So, the synergies within Process Performance Solutions between automation solutions and flow control are driven by clear customer overlap. And also, since we launched the strategy in a new structure at the Capital Markets Day in June last year. We have even gone further into that as part of our commercial excellence efforts and look into that. There is actually a greater customer overlap than what we initially thought. So that is clearly a top-line synergy between the two within the Process Performance Solutions, then between Process Performance Solutions and Biomaterial Solutions and Services. I think it is important to note, as I said earlier today, that there was a very strong industrial logic to putting automation into the bio business. The fact is now that the overall Process Performance Solutions business has gone from being over 80 percent biomaterial customers to now being less than a third of the biomaterial customers. It is of course important also to note that what you allude to is that there is also a strength in some of that automation into the bio. That is, of course, one of the things that this strategic review needs to assess: what is the synergy there? And how do we actually preserve that strength from a customer value proposition perspective?

Antti Kansanen
39:20 - 39:40

I know that it's early days regarding the strategic review, but how should we think about the structure? Would an outcome where you would separate only the flow control business out of the remainder be a possibility? Would that be a possibility or is it just a binary of Process Performance Solutions and Biomaterial Solutions and Services, or remaining with the current structure?

Thomas Hinnerskov
39:41 - 40:11

Yeah. What we are clearly looking into is taking the two segments, which are very strong individually. And they are both close to 50/50% of the bottom line and long-term value. Would it make more sense to have them as two separate listed public companies? So the purpose is to keep flow and automation together if such a separation should occur. That is the hypothesis.

Antti Kansanen
40:13 - 40:38

All right. That is very clear. Then a couple of questions on the actual Q2 performance and maybe on the Biomaterial Solutions and Services demand. You are flagging quite stable transactional parts and consumables demand, but a reduction on the field and mill improvement side. So is this just a function of certain Q2 comps, or how would you comment on the market outlook for different types of service elements within the biomaterial business?

Thomas Hinnerskov
40:39 - 41:48

Yeah, I think it is a great reflection, Antti. This is how I would think about it, which is basically twofold. First of all, we have had a number of quarters with soft, or particularly soft, and even declining parts and consumables. It is great to see that this is coming back to more normalized levels. I think it also shows that customers are getting back to the mindset that we need to operate efficiently. That is the only way to really stay competitive in the market. Then, the trend in mill improvement projects is also clear. The first half of last year was particularly strong in those. We really had a year where there was lots of customer focus on this. Now, in particular, maybe in China and Latin America, we see very little activity on the larger mill improvement projects and a strong focus instead on bigger capital projects. So I would interpret the market as there being a preservation of CapEx directed toward large capital projects rather than the larger improvement projects.

Antti Kansanen
41:51 - 42:16

All right. And then the last one from me is regarding the earnings outlook on the second half where you are essentially guiding for flat to growing earnings. Could you please elaborate on the contribution of Severn in terms of any seasonality in the business and any integration headwinds that might curtail the earnings contribution in the third and fourth quarters?

Thomas Hinnerskov
42:18 - 43:06

Yeah. Severn, as you said, we are very happy with the Severn acquisition. It will give us a slight tailwind going into the second half. It is hard to talk at this stage. We are very early in the integration. So far, we do not see any significant seasonality in that business. It is also important to remember it actually consists of three businesses with different industrial focuses, and they are also impacted by the geopolitical situation, particularly in the Middle East currently, but there is some slight tailwind going into the second half, though it is difficult to talk about the actual seasonality in that business at present.

Antti Kansanen
43:08 - 43:09

All right. Thank you very much.

Thomas Hinnerskov
43:11 - 43:12

When you get there.

Operator
43:17 - 43:22

The next question comes from Panu Mäki from Danske Bank. Please go ahead.

Panu Mäki
43:24 - 43:53

Hi. Thanks for taking my questions. I have two. Firstly, on the strategic review, I understand you have only just announced it, but can I ask about the potential negative synergies in terms of group costs. So if you separate the two, what kind of additional costs should be assumed for the new business? Is the current group SG&A to sales percentage required for that, or do you have any comments around that?

Thomas Hinnerskov
43:55 - 44:41

Yeah. As you sort of alluded to at the beginning of your question, it is very early days on that. So far, we have stated that we are initiating this strategic review. Part of that is, of course, also to look into what the potential synergies are, including the group cost structure. But I think just like we've said, we have shown over the last 12 months at least that we are committed to driving a very lean organization. You saw from Katri's presentation 79 million less SG&A cost versus 2024. So it is a focus area. Regarding how much it will be, that is something we will address if we decide to proceed with this plan. Of course, there will be more information on that topic.

Panu Mäki
44:44 - 45:06

Okay. Thank you. Secondly, on Q2 performance in Biomaterial Solutions and Services. It was quite a bit better than Q1. Could you describe what drove the delta? Was it the positive growth in services compared to Q1, or was it more cost savings coming through, or something with the equipment projects?

Thomas Hinnerskov
45:07 - 46:13

Generally, strong execution. Of course, services came out stronger, especially in the parts and consumables, which drive a good bottom line. So a little bit better service mix than in Q1 this year. That, of course, also helped with some of the cost pressures coming through. On that, we also executed quite well, accelerating some of the capital projects, with Arauco being one of them, making sure that we are actually getting ahead of the curve there to finalize that next year. So, strong delivery on the project side, a slightly better mix on the service side, some growth on the consumables, and cost containment, I would say as well. You would also know that we said in June that we would be doing some temporary layoffs here in Finland in particular. And that also gave us a little bit of tailwind in June. But the main part of that will actually be coming in the second half.

Panu Mäki
46:16 - 46:33

Okay. Thanks. Can I just ask a follow-up? Was there something unusual in the Arauco deliveries between Q1 and Q2, such that Q1 was a bit weaker and Q2 was stronger? So just thinking if the run rate is something in between those.

Thomas Hinnerskov
46:34 - 46:35

No, not really.

Panu Mäki
46:36 - 46:36

Thinking of what?

Thomas Hinnerskov
46:36 - 46:42

We've just been very keen on constantly staying ahead of the curve on that one.

Panu Mäki
46:45 - 46:46

Okay. Thank you.

Thomas Hinnerskov
46:47 - 46:48

You're welcome.

Operator
46:51 - 46:55

The next question comes from Sven Weyer from UBS. Please go ahead.

Sven Weyer
46:58 - 47:33

Yeah. Good morning and thanks for taking my questions. The first two are also on the potential breakup. I was wondering what drove the timing of the announcement? Because typically these processes tend to stem from an active shareholder who asks for these things. And then this happens. But you guys seem to be more proactive. And did you also sense more shareholder pressure in the last couple of months to do this, or what really drove the timing and the general decision to do the strategic review?

Thomas Hinnerskov
47:35 - 48:37

Yeah, thanks. I mean, clearly, like I said, last year we held our Capital Markets Day. We split the business into two different segments, the Biomaterial Solutions and Services segment and the Process Performance Solutions segment. We have then executed this, and we have looked more into inorganic growth as well. And we have now executed the Severn acquisition. So it is a very natural point to say that we have two very strong segments, both on their own and together. And so now, to take time to step back and ask the strategic question, would these two segments be stronger, easier, and better developed as standalone, or is the current structure actually a good setup for developing these two segments? So it's just a natural progression of the strategic thinking from management and the board.

Sven Weyer
48:40 - 48:49

So it was not really that during investor meetings in the last couple of months there was an increasing kind of shareholder pressure to do this.

Thomas Hinnerskov
48:50 - 49:05

No, I mean, we are hired to make sure we run the business in the best possible way. And that is where we need to take care of developing shareholder value, but also deliver to our customers the best and strongest value proposition, right? So that is what it is all about.

Sven Weyer
49:07 - 49:46

I also had a similar question to Antti regarding the synergies between the automation business and the pulp and paper machinery business. Because when you bought the business more than ten years ago, I thought there was a strong business logic to do this. You could probably argue Metso should have never spun off Valmet, and also given that Andritz has this as an integral part of their offering. So, did I understand you correctly that having a spin-off of Neles alone is not an option? So either they go together, or you keep the structure as it is.

Thomas Hinnerskov
49:49 - 50:31

Yeah. I think that there are two ways of looking at it. And that is what of course goes into the review. One is how do we preserve that offering in the Biomaterial Solutions and Services with the automation? How can we actually create and preserve that at an arm's length basis? That is one part. The other part is also that to your second part, which is that there are also synergies between flow control and automation, and there is a much stronger overlap there in the customer segment. So customer industries that they are serving within the Biomaterial Solutions and Services business, which is now less than a third of the overall PBS business.

Sven Weyer
50:35 - 51:00

A final question I have is just on the competitive environment on the board machine side, because obviously we saw now for the first time that Andritz won a huge project in Africa. Are you generally seeing more competition on those board projects? I mean, you won one in the quarter, obviously, but what is the competitive intensity that you see? Has this gone up quite a bit this year, or what do you observe?

Thomas Hinnerskov
51:02 - 51:09

I think the competitive situation is unchanged. And I think we have taken our fair share of the market this year so far on board machines.

Sven Weyer
51:12 - 51:13

Okay. Understood. Thank you.

Thomas Hinnerskov
51:14 - 51:15

Cool. Thanks, Lynn.

Operator
51:17 - 51:22

The next question comes from Tom Skogman from DNB Carnegie. Please go ahead.

Tom Skogman
51:24 - 51:35

Yes. Hello. This is Tom Skogman from DNB Carnegie. I would like to start with a question about the cash flow outlook as we are approaching the end of the Arauco delivery.

Thomas Hinnerskov
51:39 - 51:50

Yeah. I mean, I think from an Arauco perspective, I think that there is still a bit over 12 months left on that delivery, but I will let you comment a bit more specifically on the cash flow.

Katri Hokkanen
51:50 - 52:24

Yes, I think in general, as you saw from the presentation and from the numbers, the cash conversion for the last 12 months was below our average. It is good to remember that there are typically quarterly fluctuations in net working capital. And that has an impact on the cash flow. But when we look towards the future, we continue to expect cash conversion to improve during the year. It is supported by normal project phasing and working capital. We are being very disciplined, and it is still good to remember that the quarters can fluctuate.

Tom Skogman
52:26 - 52:59

The reason for really asking this is that Valmet, without Neles, used to have more or less a net cash situation. And after paying for Severn, you will have a quite big debt position. So I understand it's early days, but is there a risk that you need to raise capital to ensure both companies have strong balance sheets and that Process Performance Solutions does not start with too heavy a debt burden that could hold back future acquisitions.

Thomas Hinnerskov
53:01 - 53:37

That is a good question, Tom. I think you should consider two things. One is when we did the acquisition, the proportion of projects in the Biomaterial Solutions and Services business versus the proportion of services was much higher. So therefore, there was a much higher proportion of prepayments into these projects. So that of course impacted the net working capital positively. Then on the debt leverage, I would say even when we add Severn, will we have a debt leverage that is actually lower than last year? So I don't see any challenges on that.

Tom Skogman
53:40 - 53:42

Could you elaborate a bit further?

Thomas Hinnerskov
53:42 - 53:46

On that, it will improve over the year with the stronger. I'm sorry. Go ahead.

Tom Skogman
53:46 - 54:13

Could you open up more on that? Yeah. Could you open up a bit about the M&A pipeline? In Process Performance, you have done some very good acquisitions, and I am not talking about the next six months, but rather looking five years ahead. I mean, should we expect that business as a standalone to continue on this kind of path of finding a lot of acquisitions? What is the big picture in the M&A funnel there?

Thomas Hinnerskov
54:13 - 54:44

Yeah, I think what you can expect is twofold. One is we put more emphasis on scanning the market for suitable acquisition targets where the strategic fit is strong and where we are good owners of the asset. So that has strengthened, and we have put more effort and resources behind that. So, if we find suitable targets, expect us to continue doing good value-accretive deals on that front.

Tom Skogman
54:48 - 55:10

And then on the profile of the Biomaterial Solutions and Services business, could you somehow turn that business into more of a service business and less of a project business? Would it be possible to change how you sell, for instance, large pulp mill projects and really market the business as a service business model?

Thomas Hinnerskov
55:11 - 56:26

First of all, I think we have turned it already into much more of an aftermarket business. And that is really also what you talked about at the Capital Market Day last year, when we said what we look at is that, yes, we do the projects and how we deliver those. I don't think that will actually change much over the years. I do not see a significant path for that. However, we do see that the growth opportunity really is in the aftermarket that comes. Of course, when I say aftermarket, I mean everything from consumables and parts to mill improvement projects, large improvement projects, bigger rebuilds, and brownfield. If we think about the technology age of the two very mature markets, Europe and North America, there are quite big opportunities in terms of helping our customers drive or have more efficient equipment so that they can actually be more competitive in the market. So we are pushing this as how we see the growth. This is really about the aftermarket. The projects are sort of the cream on the cake.

Tom Skogman
56:29 - 56:40

Okay. And finally, regarding the automation solutions orders. I think they were slightly soft this quarter. Is there any reason for that?

Thomas Hinnerskov
56:41 - 56:43

Slightly. What? Sorry, I could not hear what you said. Tom.

Tom Skogman
56:44 - 56:56

The automation solution orders. I think they were a bit soft this quarter. Is there any reason to that? Is this just temporary or is there any structural change?

Thomas Hinnerskov
56:56 - 57:39

No. I think this is just between the quarters, it might vary a bit. We also had a strong Q2 last year. But we had some good wins, particularly in the Marine business, which we're very happy about. That also fueled the realization that we have a strong value proposition outside of the pulp and paper business with these technologies, both in automation solutions and in flow control. Yes, we are a market leader in those two areas in pulp and paper, but two-thirds of the business is supporting other industries in a very strong way.

Tom Skogman
57:42 - 57:42

Okay. Thank you.

Thomas Hinnerskov
57:43 - 57:44

Thank you.

Operator
57:48 - 57:53

The next question comes from Christophe from BNP Paribas. Please go ahead.

Christophe
57:56 - 58:13

Good morning. Thank you for taking my questions. I would like to start with the potential separation. And this is now a technical one. If we would like to allocate the group-level net debt to the divisional level, what would be a suitable approach to do that?

Thomas Hinnerskov
58:15 - 58:56

Yeah. Thanks for the question, Christopher. I mean, this is of course very early days and this is way too technical to be answering now. I think what is important to note on this is the following. On the net debt, we are better than last year despite the Severn acquisition. So, that is a positive thing. If it works for two entities, should we split it up. It will also work for one entity in the sum. It should be split up. It would also work for two. Of course, these two entities would have different cash requirements. And that will be taken into account should we get to that stage in terms of the balance sheet.

Christophe
58:58 - 59:26

Okay. And the second question is more strategically on the trends we have been seeing in service revenues and Biomaterial Solutions and Services. Biomaterial Solutions and Services. Do you think the change in the operational model has negatively impacted the operating performance and has contributed to the revenue decline you have faced in the first six months of the year, or has this been simply driven by the adverse market conditions? Thank you.

Thomas Hinnerskov
59:28 - 59:53

It is clear we have had some quite challenging market conditions over the last 12 months. What I would also pay attention to is that the operating model has been driving 79 million in bottom-line SG&A impact for the last 12 months. So that is of course a major contribution to the profitability levels that we are seeing now, despite the softer market that we are also experiencing in Biomaterial Solutions and Services.

Christophe
59:55 - 59:56

Okay. Thank you.

Thomas Hinnerskov
59:59 - 60:08

And you should also consider that. The big change on some of these services is actually on the margin improvement projects.

Christophe
60:10 - 60:11

Understood.

Thomas Hinnerskov
60:13 - 60:14

Thanks, Christopher.

Operator
60:16 - 60:20

The next question comes from Michael Doble from Nordea. Please go ahead.

Michael Doble
60:22 - 61:18

Yes. Hi. Good morning from India. Two questions, please. Firstly, on the project business pipeline. How would you describe that now? I think you have received one order from China in the quarter. You have been talking about the pipeline over there. We have seen the CNPC project being a bit delayed. If you could talk a bit about what you are seeing out there when it comes to the big projects and what your expectations are. And then, secondly, on the service outlook overall. So I think you are guiding for a soft market. At the same time, you are saying that you are seeing some signs of improvement. So we are wondering how we should read this. As you pointed out, we have seen multiple quarters of weakness already in this business. Is it fair to assume that slight improvements, perhaps coupled with weak comps, should actually mean that this business should turn back to growth in the second half? Or how do you view the situation?

Thomas Hinnerskov
61:20 - 63:22

Yeah. Good observations. Michael. If you just take on the project pipeline first, as I said, we do see better activity in terms of discussions with customers than what we saw maybe six months ago. So that is, I think, a positive. Of course, it is difficult to predict timing between the quarters. But I would also emphasize that this quarter is one I see as a positive as well. Yes, there was one bigger order that was in the triple-digit millions. However, the rest was very broad-based, both in terms of geographies they are coming from and the business areas they are coming from. So both tissue, board, and pulp have all received large and sizable orders across different geographies. I think that is a positive, as it is not just a one-off. And then it looked good. But actually, it was a good foundation. But also, the conversations we have with customers are also fairly broad-based. Then, as I said, it is also a little bit hard to predict between the quarters on the service side. Uh, yes. Good to see that the parts and consumables are stabilizing and coming back up, with customers being more focused on operational efficiency and maintaining the equipment rather than sweating the assets, which we have seen in the past 12 months, where the sharing of spare parts between sites has been reduced and has reached a natural low level. And then, but I do want to, and that is what we are emphasizing a little bit. The visibility is and has been lower the last 12 months than what we've actually seen historically.

Panu Mäki
63:25 - 63:26

Okay.

Michael Doble
63:27 - 63:28

Fair enough. Thank you very much.

Operator
63:34 - 63:45

As a reminder, if you wish to ask a question, please dial pound key five on your telephone keypad. The next question comes from Antti Kaasinen from SEB. Please go ahead.

Antti Kansanen
63:48 - 64:17

Yeah. Thanks for taking my follow-up. My question is on cost inflation and backlog and order margins. How do you see pressure coming from your suppliers and obviously freight costs as well, compared to the open project backlog that you have and the new orders that you have taken in the quarter going into next year's margin forecasts. Is there pressure on margins, or can you price them accordingly?

Thomas Hinnerskov
64:19 - 65:53

Yeah. Clearly, this is an important area for us, as management is constantly having visibility into the inflation, as you rightly point out. So, freight has gone up quite substantially lately. And that is, of course, something that we have been managing. I would say we have been successful on our whole sourcing side, but also on the pricing, by actually passing the cost inflation on. And maybe I should also emphasize that the strategic initiative we made last year with forming our global supply function and recruiting people from the outside, really setting the strongest team you can think of, has paid off. So even though they might have started a little bit late towards the end of last year in getting the team together. They have actually delivered in an accelerated way for this year. We have seen a double-digit impact, in the low teens, in this first half. We will see the same trend in the second half. We also have the bold action. We took action on some of the sites, both in Europe and in China, that will have a €200 million impact. Impact starting in 2027 as well. So that is an important part of us staying competitive, both in terms of being competitive, but also making sure that we preserve the margins.

Antti Kansanen
65:55 - 66:09

All right. And then regarding the timelines and revenue contributions from the project, is there anything you would want to guide in terms of the second half and how much is still left for next year in terms of the project revenues?

Unknown 2
66:10 - 66:11

Um, hi.

Katri Hokkanen
66:12 - 66:30

We have been saying in the call earlier that we were expecting roughly 400 million for this year, but actually now, due to the things that we have already discussed today, we are estimating that the revenue recognition would be around 500 million this year, and then the remainder goes to next year. But now it is very active.

Antti Kansanen
66:30 - 66:36

How much was it last year? Just a reminder.

Katri Hokkanen
66:38 - 66:41

It was roughly 400 million.

Antti Kansanen
66:43 - 66:45

All right. Thank you. That's all from me.

Katri Hokkanen
66:46 - 66:46

Thank you.

Operator
66:50 - 66:54

There are no more questions at this time. So I hand the conference back to the speakers.

Pekka Rouhiainen
66:56 - 67:10

Okay. Thank you. Thank you for that. There are still a few questions here on the platform that weren't already addressed. So, first of all, does the guidance now include the Severn acquisition? Could you please confirm?

Thomas Hinnerskov
67:11 - 67:53

Yes. As I said, we will get a slight tailwind from the Severn acquisition. We also will get some tailwind from the cost-saving actions we've taken, not just the cost control actions we've taken over the year, but also the temporary layoff that we announced earlier in the second quarter will give us some benefit into the second half of the year. So year-to-date, we are slightly ahead. We had a good trend in Q2 versus Q1. And then, Severn gives a little bit of tailwind. The big swing factor is the service, especially on the parts and consumables and how we can get that through the order backlog and into net sales.

Pekka Rouhiainen
67:55 - 68:03

Thanks. And then a follow-up from Christian here. So could you consider selling one of the segments rather than listing?

Thomas Hinnerskov
68:06 - 68:54

I think. We more or less addressed that a little bit earlier today in the call, I think. So what this review is about is really whether it would place us in a better position to develop these two segments if they were standalone rather than together? So that is why we have come forward and proposed two potential listed companies. Of course, the board will support all shareholders and make the best decision for the shareholders and how to actually develop the company going forward, which means that there can, of course, be other ideas coming to the table and then we will have to look at those.

Pekka Rouhiainen
68:56 - 69:04

Sure. Thank you Thomas. That is all from the webcast. So now handing over back to you, Thomas, for final remarks.

Thomas Hinnerskov
69:04 - 71:01

Thank you very much, and thanks, everyone, for joining us today. I would like to thank all our customers for their trust and also all our Valmet employees for their commitment and hard work throughout the quarter. It has definitely been a challenging quarter. Just look at the news and you will realize that many challenges arise when you run a global company. So, really well done by the 20,000 Valmet employees. And as you have heard today, we have an important period ahead of us. What gives me real confidence is the strength of the business that we have built, the two different segments, the commitment of our people, and the opportunities that we see ahead of us, regardless of the outcome of the review. Those fundamentals really remain unchanged. We have strong value propositions. We have a strong offering and great committed employees. So we continue running the business with full speed ahead. Before we close, I do want to extend a special thanks to Katri. This is your final earnings call. I think it is number 17 as CFO and actually the eighth together with me. I do want to thank you for your very strong support. Great discussions. In terms of everything from how to run the business and strategic decisions, to preparing for these kinds of calls and going through all the details that come with that. So huge thanks. To those on the call who might be following where Katri is going, please make sure you ask some truly challenging questions, particularly in Q3 this year when Katri has just joined and is very new. On that happy note, I do thank you very much for joining, and enjoy your summer, and see you soon after the summer holidays. Take really good care and all the best.

Continue to the webcast
Lundbeck - Præsentation af delårsrapport for Q3 2026
Language: Danish11/12/2026, 12:00 PM
H. Lundbeck A/S ventes at offentliggøre sin delårsrapport for Q3 2026 den 11. november 2026. Dagen efter, den 12. november kl. 13.00, vil Jens Høyer, Vice President & Head of Investor Relations, præsentere resultaterne og svare på spørgsmål fra publikum i et live online event.
Wirtek - Presentation of Q3 2026 Interim Report
Language: English11/12/2026, 10:00 AM
Wirtek is expected to release its Q3 2026 interim report on 11 November 2026. The next day at 11.00 CET, CEO Michael Aaen and CFO Mads Greiffenberg will present the results in a virtual live event with a Q&A session.
Rovsing - Præsentation af Interim Management Statement for Q1 2026/27
Language: Danish11/11/2026, 12:00 PM
Rovsing ventes at offentliggøre sin Interim Management Statement for Q1 2026/27 den 10. november 2026. Den 11. november kl. 13.00 vil ledelsen præsentere kvartalets tal, give en status på udviklingen i forretningen samt følge op på de seneste selskabsnyheder. Præsentationen efterfølges af en Q&A-session.
DADC - Præsentation af handelsopdatering for Q3 2026
Language: Danish11/5/2026, 8:30 AM
Du kan allerede nu tilmelde dig eventet og sende dine spørgsmål ind. Du behøver ikke at deltage live for at sende spørgsmål til præsentationen. Danish Aerospace and Defence Company (DADC) ventes at offentliggøre sin handelsopdatering for 3. kvartal 2026 den 4. november 2026. Dagen efter, den 5. november kl. 09.30, vil selskabets CEO, Thomas A.E. Andersen, præsentere resultaterne samt svare på spørgsmål i et online live-event.
Boozt AB, Audiocast, Q3'26
Language: English11/3/2026, 8:30 AM
Herman Landin Thank you and good morning to all. Welcome to our Q3 2026 presentation. So, let's turn to the first slide, please. We will follow our usual agenda. I'll take you through the highlights a…
NORDEN – Presentation of Q3 2026
Language: English10/29/2026, 9:30 AM
NORDEN is expected to release its Q3 2026 results on 29th October 2026. The same day at 10.30am, management will present the results in an online event followed by a Q&A.
Agillic – Præsentation af kvartalsrapporten for Q3 2026
Language: Danish10/22/2026, 8:00 AM
Du kan allerede nu tilmelde dig eventet og sende dine spørgsmål ind. Du behøver ikke at deltage live for at sende spørgsmål til præsentationen. Agillic offentliggør kvartalsrapporten for Q3 2026 den 22. oktober 2026. Samme dag kl. 10:00 vil selskabets CEO Christian Samsø præsentere resultaterne, gennemgå forventningerne til resten af 2026, give en opdatering på markedsforholdene og besvare spørgsmål ved et online live-event.
Nordea third-quarter results 2026
Language: English10/15/2026, 8:00 AM
Head of Investor Relations Good morning and welcome to Nordea's third-quarter 2026 results. Nordea's third-quarter 2026 results. I am your Head of Investor Relations. As usual, we will start with the…
GreenMobility - Presentation of the Q3 2026 Trading Statement
Language: English10/14/2026, 11:00 AM
GreenMobility is expected to release its Q3 2026 Trading Statement on 8 October 2026. On 14 October at 13:00 CEST, CEO Kasper Gjedsted will present the figures and answer questions in a live online event.
Rovsing – Præsentation af årsrapport 2025/26
Language: Danish9/28/2026, 9:00 AM
Rovsing ventes at offentliggøre årsrapporten for regnskabsåret 2025/26 den 25. september 2026. Den 28. september kl. 11.00 vil ledelsen præsentere årets resultater, give en status på udviklingen i forretningen samt kigge frem mod 2026/27. Præsentationen efterfølges af en Q&A-session
Danish Aerospace and Defence Company – Præsentation af H1 2026 resultater
Language: Danish8/25/2026, 8:00 AM
Danish Aerospace and Defence Company (DADC) ventes at offentliggøre selskabets rapport for H1 2026 den 24. august 2026. Dagen efter, den 25. august kl. 10.00, vil selskabets CEO, Thomas A.E. Andersen, præsentere resultaterne samt svare på spørgsmål i et online live-event.
North Media – Præsentation af regnskabet for 2. kvartal 2026
Language: Danish8/21/2026, 12:00 PM
Tilmeld dig North Media’s præsentation af regnskabet for 2. kvartal 2026 – fredag d. 21. august 2026 kl. 14.00. Se med når ledelsen i North Media gennemgår kvartalsregnskabet der offentliggøres dagen før, og hvordan første halvår af 2026 er forløbet, samt svarer på spørgsmål.
Wirtek – Presentation of Q2 2026 Interim Report
Language: English8/14/2026, 9:00 AM
Wirtek is expected to release its Q2 2026 interim report on 12 August 2026. Friday 14 August at 11.00 CEST, CEO Michael Aaen and CFO Mads Greiffenberg will present the results in a virtual live event with a Q&A session.
Boozt AB, Audiocast, Q2'26
Language: English8/14/2026, 7:30 AM
Herman Thank you. Good morning to all, and welcome to our Q2 2026 webcast. So let's turn to the first slide, the agenda for today's presentation. We will follow our usual agenda. I'll take you through…
NORDEN – Presentation of the quarterly report for Q2 2026
Language: English8/13/2026, 8:30 AM
NORDEN is set to release its quarterly report for Q2 2026 on the morning of Thursday 13 August 2026. On the same day at 10:30 AM, we are pleased to invite you to a presentation of the financial results with CEO Jan Rindbo and CFO Martin Badsted, who will also answer questions from the audience.
Sampo Oyj, Audiocast, Q2'26
Language: English8/12/2026, 7:30 AM
Mirko Hurmerinta Good morning, everyone, and welcome to Sampo Group's conference call on second quarter 2026 results. My name is Mirko Hurmerinta, the interim Head of IR at Sampo. I am joined on the c…
Nordea half-year results 2026 webcast
Language: English7/16/2026, 8:00 AM
Ilkka Good morning and welcome to Nordea's second quarter 2026 results. I am Ilkka, Head of Investor Relations. As usual, we'll start with the presentation by Group CEO Frank Vang-Jensen, followed by…
NORDEN – Presentation of the quarterly report for Q1 2026
Language: Danish5/6/2026, 8:30 AM
NORDEN is set to release their quarterly report for Q1 2026 on the morning of Wednesday 6 May 2026. On the same day at 10:30 AM, we are pleased to invite you to a presentation of the financial results with CEO Jan Rindbo and CFO Martin Badsted, who will also answer questions from the audience.
Sampo Oyj, Audiocast, Q1'26
Language: English5/6/2026, 7:30 AM
Mirko Hurmerinta Good morning, everyone, and welcome to Sampo Group's conference call on first quarter 2026 results. My name is Mirko Hurmerinta and I am the interim Head of Investor Relations at Samp…
Boozt AB, Audiocast, Q1'26
Language: English4/24/2026, 7:30 AM
Herman Good morning and welcome to our presentation of our Q1 2026 report. Let's just go to the agenda slide. We will have the usual agenda for the presentation. And I will present the highlights of t…